Cargando…
Proteomic profiling of sudden cardiac death with acquired cardiac hypertrophy
BACKGROUND: Cardiac hypertrophy, which develops in middle-aged and older individuals as a consequence of hypertension and obesity, is an established risk factor for sudden cardiac death (SCD). However, it is sometimes difficult to differentiate SCD with acquired cardiac hypertrophy (SCH) from compen...
Autores principales: | Kakimoto, Yu, Ueda, Atsushi, Ito, Masatoshi, Tanaka, Masayuki, Kubota, Tomoko, Isozaki, Shotaro, Osawa, Motoki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10421815/ https://www.ncbi.nlm.nih.gov/pubmed/37284852 http://dx.doi.org/10.1007/s00414-023-03038-6 |
Ejemplares similares
-
Overexpression of miR-221 in sudden death with cardiac hypertrophy patients
por: Kakimoto, Yu, et al.
Publicado: (2018) -
Myocardial cathepsin D is downregulated in sudden cardiac death
por: Kakimoto, Yu, et al.
Publicado: (2020) -
Myocardial lipofuscin accumulation in ageing and sudden cardiac death
por: Kakimoto, Yu, et al.
Publicado: (2019) -
Evaluation of cardiac hypertrophy in the setting of sudden cardiac death
por: Cunningham, Kristopher S., et al.
Publicado: (2019) -
Non-polyalanine repeat mutation in PHOX2B is detected in autopsy cases of sudden unexpected infant death
por: Ueda, Atsushi, et al.
Publicado: (2022)